NMTC

NeuroOne Medical Technologies Corporation · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website n1mtc.com
Employees(FY) 16
ISIN US64130M2098

Performance

-0.72%

+14.7%

-18.91%

-7.01%

-52.01%

YTD

-45.06%

Profile

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Advanced Technical Analysis

Technical Analysis of NMTC 2024-12-20

The stock indicators reflect a neutral sentiment overall, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators Score of 60 suggests some bullish momentum. The combined Technical Score of 55 reinforces this neutral outlook, indicating that while there are positive signals, caution is still warranted as the market...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NMTC

Stock Rank

Recent News & Updates

2024-12-16 19:30
NeuroOne Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025(Globenewswire)
2024-12-03 19:30
NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time(Globenewswire)
2024-12-03 02:45
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing(Yahoo Finance)
2024-11-12 20:30
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event(Accesswire)
2024-10-31 04:01
NeuroOne Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF Ablation System(Globenewswire)
2024-10-23 21:00
NeuroOne Medical Technologies to Present at the 2024 ThinkEquity Conference(Globenewswire)
2024-09-23 21:30
NeuroOne Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference(Globenewswire)
2024-09-09 21:00
NeuroOne Announces Breakthrough Case Completed with OneRF Ablation System at the University Hospitals in Cleveland(Globenewswire)
2024-09-05 06:23
NeuroOne to Present at the H.C. Wainwright 26th Annual Global Investment Conference(Globenewswire)
2024-08-14 04:00
NeuroOne Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-08-11 23:30
NeuroOne to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14(Globenewswire)
2024-08-04 21:00
NeuroOne Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility(Globenewswire)
2024-06-24 21:00
NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System(Globenewswire)
2024-06-19 21:30
NeuroOne Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation(Globenewswire)
2024-05-14 08:57
NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024(Investorplace)
2024-05-14 04:00
NeuroOne Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-05-10 02:43
NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14(Globenewswire)
2024-04-09 21:00
NeuroOne CEO Dave Rosa Featured on Bloomberg Technology(Globenewswire)
2024-04-08 21:05
NeuroOne Announces First Implant of OneRF Ablation Electrodes(Globenewswire)
2024-04-03 21:00
NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co.(Globenewswire)
2024-03-25 21:00
NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System(Globenewswire)
2024-03-07 23:00
NeuroOne to Participate in the 36th Annual Roth Conference(Globenewswire)
2024-02-23 04:10
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-02-13 03:00
NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-02-08 02:30
NeuroOne to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13(Globenewswire)
2023-12-14 03:15
NeuroOne Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update(Globenewswire)
2023-12-10 19:00
NeuroOne Receives FDA 510(k) Clearance to Market its OneRF Ablation System(Globenewswire)
2023-12-07 03:30
NeuroOne to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14(Globenewswire)
2023-11-15 19:00
NeuroOne Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe(Globenewswire)
2023-11-14 04:15
NeuroOne Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.